Keeping you up to date on recent developments in orthopedics, including: UCLA scientists create first roadmap of human skeletal muscle development; Excess coffee consumption a culprit for poor health; Arthritis clinical trial shows support for dextrose injection to alleviate knee pain; Gene therapy in mice builds muscle, reduces fat.
Keeping you up to date on recent developments in oncology, including: New nanoparticle proposed as treatment for a ‘wide range of cancers’; CD163-expressing macrophages a sign of poor outcomes; Mevion inks deal for protons in Texas; PSMA PET-CT show well in study of prostate cancer metastasis.
By delivering the protein follistatin via gene therapy, researchers at Washington University in St. Louis were able to increase skeletal muscle mass, decrease fat, and reverse obesity-related arthritis in mice who developed osteoarthritis as a result of a high-fat diet.
Keeping you up to date on recent developments in cardiology, including: Necklace used to detect abnormal heart rhythm; Link found between blood vessel inflammation, malfunctioning mitochondria; Liver-specific pre-eclampsia treatment is maternal-specific, as well.
Keeping you up to date on recent developments in neurology, including: Focused ultrasound opens brain for gene therapy; Study links early sleep problems to autism diagnosis; New trial platform could accelerate finding a cure for Parkinson's disease.
Keeping you up to date on recent developments in diagnostics, including: Circulating progesterone and breast cancer risk; Llamas aid in fight against COVID-19; Transcriptomic insights into Parkinson’s disease.
Keeping you up to date on recent developments in orthopedics, including: Scientists regenerate neurons in mice with spinal cord injury and optic nerve damage; Trial questions benefits of organic nitrates for bone health; Mind-controlled arm prostheses that 'feel' are now a part of everyday life; Biomaterial immune control discoveries could reduce implant rejection.
A multi-institutional group led by the University of California at San Francisco’s Quantitative Biosciences Institute (QBI) has identified more than 200 host proteins that interacted with SARS-CoV-2 viral proteins during infection, creating “a blueprint of how SARS-CoV-2 hijacks human cells.”
RSS
